Published in Int J Colorectal Dis on June 15, 2013
Carcinoid tumors are 15 times more common in patients with Crohn's disease. Inflamm Bowel Dis (2007) 1.64
Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev (1994) 1.26
Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol (1997) 1.21
The coexistence of carcinoid tumor and Crohn's disease. J Clin Gastroenterol (1986) 0.96
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol (2005) 2.90
Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA (2003) 2.69
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. Gastroenterology (2011) 2.21
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology (2004) 2.16
A pilot whole systems clinical trial of traditional Chinese medicine and naturopathic medicine for the treatment of temporomandibular disorders. J Altern Complement Med (2008) 2.10
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. Eur J Nucl Med Mol Imaging (2013) 2.06
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 1.81
Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol (2007) 1.77
Warm water or oil-assisted colonoscopy: toward simpler examinations? Am J Gastroenterol (2007) 1.77
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology (2012) 1.68
Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med (2007) 1.64
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol (2003) 1.51
Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol (2007) 1.49
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol (2011) 1.42
Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med (2005) 1.40
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology (2007) 1.24
Ileal pouchitis-related arthritis. Semin Arthritis Rheum (2002) 1.23
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol (2012) 1.22
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors. J Nucl Med (2010) 1.19
Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis (2002) 1.15
High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum (2007) 1.12
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis (2010) 1.11
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. Am J Gastroenterol (2005) 1.11
Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol (2003) 1.10
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol (2005) 1.10
Coagulative disorders in human acute pancreatitis: role for the D-dimer. Pancreas (2003) 1.09
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Endocr Relat Cancer (2007) 1.07
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis (2005) 1.06
Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis (2009) 1.06
Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis (2014) 1.04
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis (2005) 1.03
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol (2006) 1.02
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nucl Med (2010) 1.02
Effect of secretin on serum pancreatic enzymes and on the Wirsung duct in chronic nonpathological pancreatic hyperenzymemia. Pancreatology (2003) 1.01
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J Proteome Res (2009) 1.01
European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis (2015) 1.01
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging (2008) 0.99
Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol (2006) 0.98
Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis (2009) 0.98
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
Intestinal epithelial cells in inflammatory bowel diseases. World J Gastroenterol (2010) 0.97
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology (2011) 0.96
Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET. Biomed Pharmacother (2008) 0.95
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol (2010) 0.94
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. Pancreas (2010) 0.93
Adult attachment and early parental experiences in patients with Crohn's disease. Psychosomatics (2010) 0.93
Parental bonding and inflammatory bowel disease. Psychosomatics (2010) 0.93
Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol (2006) 0.93
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis (2007) 0.91
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2010) 0.91
⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. Eur J Nucl Med Mol Imaging (2012) 0.91
Patient-reported experiences with first-time naturopathic care for type 2 diabetes. PLoS One (2012) 0.91
Survival in HIV-1-positve adults practicing psychological or spiritual activities for one year. Altern Ther Health Med (2007) 0.91
Are there prognostic factors related to recurrence in pancreatic endocrine tumors? Pancreatology (2010) 0.91
Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum (2005) 0.90
Antimicrobials in the management of inflammatory bowel disease. Digestion (2006) 0.89
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study. Inflamm Bowel Dis (2011) 0.89
Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol (2006) 0.89
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. J Clin Gastroenterol (2005) 0.88
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med (2004) 0.87
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. Eur J Gastroenterol Hepatol (2005) 0.86
The naturopathic medical research agenda: the future and foundation of naturopathic medical science. J Altern Complement Med (2006) 0.86
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Investig (2004) 0.86
PET/CT with 68Gallium-DOTA-peptides in NET: an overview. Eur J Radiol (2010) 0.86
Binaural beat technology in humans: a pilot study to assess neuropsychologic, physiologic, and electroencephalographic effects. J Altern Complement Med (2007) 0.85
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. Pancreas (2014) 0.85